|
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
RECRUITINGPhase 4Sponsored by University of Rochester
Actively Recruiting
PhasePhase 4
SponsorUniversity of Rochester
Started2022-05-27
Est. completion2025-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations19 sites
View on ClinicalTrials.gov →
NCT05034432
Summary
To investigate the effect of VTA ablation at the time of LVAD implant to see if it can reduce the incidence of VTA after surgery
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Age \> 18 years * Presence of advanced cardiomyopathy (of all INTERMACS classification) and eligible for LVAD implant per the decision of the Heart Failure clinical team * Implanted cardioverter defibrillator (ICD) any time in past with remote monitoring or planned to undergo ICD (or ICM as an alternative, if an ICD cannot be implanted for a clinical reason) implant within the index hospitalization for LVAD implant * History of treated or monitored sustained (i.e., \>30 seconds in duration ) VT or VF episode within the past 5 years. Exclusion Criteria: * Past successful VTA ablation without recurrent VTA prior to LVAD implant (Patients who continue to experience VTA post ablation and pre LVAD implant qualify to be enrolled) * Participation in other clinical trials (observational registries are allowed with approval) * Unable or unwilling to provide informed consent
Conditions3
ArrythmiaCardiomyopathiesHeart Disease
Locations19 sites
Banner University Medical Center
Phoenix, Arizona, 85006
UCLA Cardiac Arrthmia Center
Los Angeles, California, 90095
University of California San Francisco
San Francisco, California, 94143
Medstar Washington Hospital Center
Washington D.C., District of Columbia, 20010
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 4
SponsorUniversity of Rochester
Started2022-05-27
Est. completion2025-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations19 sites
View on ClinicalTrials.gov →
NCT05034432